U.S. Residential REITs Stock News

If you’ve been watching Hyatt Hotels stock lately, it’s been anything but dull. Whether you’re debating whether to hang on, take some profits, or explore an entry point, there’s been just enough action and news to keep investors on their toes. Let’s cut to the chase: Hyatt’s shares closed most recently at $144.35, and while the last week might have felt a bit bumpy with a -3.4% slide, the past month did sneak in a modest 1.6% gain. Year-to-date returns sit at -7.7%, but step back a bit and...

Herc Holdings (NYSE:HRI) grabbed the spotlight after reporting strong third-quarter revenue growth that exceeded analyst expectations. The company reaffirmed its full-year revenue guidance, even as it navigated integration challenges from acquiring H&E Equipment Services. See our latest analysis for Herc Holdings. Shares of Herc Holdings have staged a dramatic short-term rebound, with a 16.6% one-month share price return and an 18.2% gain over the last 90 days following the upbeat Q3 revenue...

Akebia Therapeutics recently announced it will no longer pursue a broad U.S. label expansion for its anemia drug Vafseo in chronic kidney disease patients not on dialysis, after the FDA rejected the proposed trial design and required a much larger, more expensive study. This shift prompts Akebia to concentrate future efforts on more narrowly defined patient subgroups and dialysis patients, potentially altering its growth trajectory in the CKD anemia treatment market. We’ll explore how...

Thinking about what to do with MKS stock? You are not alone. The share price has been on a bit of a roller coaster lately, up a striking 15.3% over the last month. This follows a robust year with a gain of 34.5%, pushing its year-to-date return to 32.5%. Such numbers tend to grab the attention of investors, especially when the big surges are tied to key market shifts or strategic developments in the company’s roadmap. One reason MKS has been in the spotlight is its recent partnership...

Amphenol Corporation recently completed a series of major debt and fixed income offerings, including the issuance of senior notes totaling over US$8 billion with maturities ranging from 2027 to 2055, following strong third-quarter results and a 52% rise in its quarterly dividend. The proceeds from this debt issuance are intended to help fund Amphenol's acquisition of CommScope Holding Company's Connectivity and Cable Solutions businesses, further expanding its position in the interconnect...

Energy Transfer (NYSE:ET) just announced a higher quarterly cash distribution for common unitholders, marking an increase of over 3% from last year. For investors, this signals ongoing strength in the company’s cash flows and a consistent strategy of shareholder returns. See our latest analysis for Energy Transfer. Energy Transfer’s share price has drifted lower so far in 2025, settling at $16.99, and is down nearly 14% year-to-date, even as the company continues to raise distributions and...

USA Rare Earth recently caught investors’ eyes as its stock delivered an impressive 81% return over the past 3 months. Much of the attention is now focused on how sustainable this momentum might be. See our latest analysis for USA Rare Earth. After such a remarkable 12-month total shareholder return of nearly 87%, USA Rare Earth's recent 81% 3-month share price return stands out, even with steeper pullbacks last week. Momentum is clearly building as investors weigh up both growth stories and...

Recent reports show more consumers are embracing cost-saving habits, such as buying in bulk or watering down household products. This shift in frugality has prompted investors to take a closer look at Clorox (CLX) and its exposure to changing spending patterns. See our latest analysis for Clorox. Clorox shares have faced mounting pressure this year, notching a 1-year total shareholder return of -23.77% as spending habits have shifted and frugality sets the tone for the everyday consumer...

Ameris Bancorp (ABCB) reported net profit margins of 35.2% for the latest period, up from last year’s 31.5%, indicating stronger profitability. Over the past five years, earnings have grown by an average of 1.8% annually, while the most recent year saw a much faster 20.6% gain. The company’s high-quality results and ongoing profit momentum suggest investors may focus on sustainability and future growth, especially as forecasts call for revenue and earnings to continue rising, though...

ACV Auctions (ACVA) is in the spotlight after recent analyst notes flagged persistent softness in its results. Ongoing challenges around gross margins and marketing efficiency continue to raise questions about the company’s long-term profitability. See our latest analysis for ACV Auctions. ACV Auctions’ share price has taken a considerable hit this year, falling more than 56% year-to-date as weak quarterly results and cautious industry outlooks have weighed on sentiment. Despite a modest...

PSB Holdings (PSBQ) posted a net profit margin of 25.4%, up from 20.8% in the prior year, and recorded earnings growth of 38.3% over the past year, sharply reversing its five-year average decline of -3.9% per year. Shares are trading at $25.31, which comes at a discount to an estimated fair value of $32.56. The company also has a notable 8.3x Price-to-Earnings ratio, which is well below both industry and peer averages. This surge in profitability, combined with high-quality earnings and an...

If you’ve been following Xylem lately, you may be wondering if this water technology stock still has room to run, or if it is already priced for perfection. Xylem’s shares are up a strong 29.8% so far this year, building on an impressive 74.1% gain over the past five years. Even in the last month alone, the stock has climbed another 5.2%, showing just how confident investors seem to feel. Of course, moves like these rarely come out of nowhere. Xylem has caught the market’s attention with...

Amcor recently published its fiscal 2025 Sustainability Report following its combination with Berry Global, highlighting its achievement of key environmental goals including using 10% post-consumer recycled plastic and designing 72% of its packaging for recyclability. Significantly, Amcor also reported a 20% reduction in greenhouse gas emissions and doubled its renewable electricity use to 30% of total energy consumption since 2021. We'll now examine how Amcor's progress in recycled and...

M&T Bank (MTB) recently reported higher third-quarter net interest income and net income compared to last year, delivering a performance update that caught investors’ attention. The bank also unveiled a new fixed-income offering of depositary shares, which adds another dimension to its capital strategy. See our latest analysis for M&T Bank. M&T Bank’s recent third-quarter update arrived amid a challenging stretch for its stock. While October saw active headlines, ranging from new depositary...

Alkermes (ALKS) shares have shown some movement recently, drawing investor attention toward the company’s recent performance and trends. With the stock up 4% in the past month and over 17% higher in the past year, many are taking a closer look at its fundamentals. See our latest analysis for Alkermes. Momentum has been building for Alkermes, with a recent 11.2% one-month share price return helping push its total shareholder return to 17.3% over the past year. This performance points to...

Comerica Incorporated recently reported its third quarter 2025 results, highlighting net interest income of US$574 million and net income of US$176 million, alongside net charge-offs of US$32 million for the quarter, up from US$11 million a year ago. The combination of higher net charge-offs, ongoing share repurchases, and plans to affirm an upcoming dividend illustrates a complex earnings picture that may have influenced investor sentiment around the company's risk profile and capital...

Tourmaline Bio (TRML) stock has drawn investor attention recently, thanks to significant price movements over the past three months. The company’s performance has surfaced in market discussions as bio-pharma investors look for catalysts. See our latest analysis for Tourmaline Bio. Tourmaline Bio’s share price return over the past year stands out, with momentum accelerating sharply in the past quarter. The company posted a 116.81% share price return over the last 90 days and a robust 132.46%...

Lakeland Financial (LKFN) posted net profit margins of 39.5% for the period, marking a slight pullback from last year’s 41%. Over the last five years, the company’s earnings have grown at an average of 1.2% annually, with management now forecasting a 6.7% annual earnings growth and 7.1% revenue growth going forward, both trailing broader US market benchmarks. Investors might view these numbers as a sign of steady but modest profitability, with strong underlying quality but only moderate...

Global Industrial (GIC) has released its third-quarter results, revealing year-over-year growth in both revenue and profit. However, the numbers landed below what Wall Street was expecting, which prompted a sharp reaction from investors. See our latest analysis for Global Industrial. After a steady year marked by revenue gains and a notable boost in profitability, Global Industrial’s latest earnings miss delivered a jolt to momentum. The stock quickly slid 14.6% after results, even though its...

Radware (RDWR) has rolled out expanded features for its AI SOC Xpert platform, unveiling new dashboards focused on Application SOC Xpert and improved DDoS Protection capabilities. These updates enhance the company’s competitive position in cybersecurity. See our latest analysis for Radware. Radware’s latest platform updates arrive amid steadily building momentum, reflected in a year-to-date share price return of 19.3% and a 12-month total shareholder return of 18.2%. The boost to its...

Disc Medicine (IRON) completed a $250 million follow-on equity offering and also highlighted major progress in its pipeline, including a key FDA voucher for bitopertin in erythropoietic protoporphyria. This dual update draws investor attention to the company’s near-term momentum. See our latest analysis for Disc Medicine. Disc Medicine’s 1-year total shareholder return of nearly 91% stands out, with momentum accelerating further thanks to the recent 40% year-to-date share price return. Its...

Abbott Laboratories (ABT) shares have settled a bit lower over the past month, tracking a 5% dip as investors reassess healthcare stocks. The stock’s recent performance invites a closer look at its valuation and underlying trends. See our latest analysis for Abbott Laboratories. Abbott Laboratories’ momentum has leveled off lately following a steady string of gains earlier this year, as investors weigh shifting healthcare trends and uncertainties around the sector. Over the past year,...

JD.com (NasdaqGS:JD) is making headlines with the launch of its first electric vehicle and the rollout of a new humanoid robot for Chinese consumers. These technology-forward moves reflect the company’s growing ambitions beyond e-commerce. See our latest analysis for JD.com. JD.com’s fresh push into EVs and robotics comes as the company works to offset recent challenges, including tighter regulations around digital assets in China and shifting investor sentiment. While the share price has...

First Busey Corporation recently reported its third quarter 2025 financial results, with net interest income rising to US$155.14 million and adjusted earnings per share reaching US$0.64, both exceeding analyst expectations. The company’s year-on-year revenue growth was very large, highlighting substantial momentum in its core banking operations during the quarter. We’ll examine how First Busey’s sharp revenue growth and earnings beat contribute to its evolving investment narrative. The end...